- A Clinical Analysis on Liver Transplantation for Hepatocellular Carcinomas
-
Park JH, Kim DG, Choi SH, Moon IS, Lee MD, Kim IC
- KMID: 772520
- Korean J Gastroenterol.
- 2003 Jul;42(1):42-49.
BACKGROUND/AIMS: Currently, the role of liver transplantation in the treatment of hepatocellular carcinoma (HCC) with cirrhosis is controversial. What remain to be determined are the best treatment protocol and... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical Treatment of Sclerosing Hepatocellular Carcinoma
-
Kim BS, Lee SG, Hwang S, Lee YJ, Park KM, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Moon KM
- KMID: 760673
- Korean J Hepatol.
- 2006 Sep;12(3):412-419.
BACKGROUND/AIMS: Sclerosing hepatocellular carcinoma (HCC) is an unusual subtype of HCC that is characterized by an embedded dense fibrous stroma in the tubular neoplastic structures. We aimed to assess... -
- CITED
-
- Close
- SHARE
-
- Close
- The Comparative Results of Radiofrequency Ablation versus Surgical Resection for the Treatment of Hepatocellular Carcinoma
-
Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Hwang YJ, Kim YI
- KMID: 760581
- Korean J Hepatol.
- 2005 Mar;11(1):59-71.
BACKGROUND/AIMS: Although surgical resection remains the gold standard of therapy for hepatocellular carcinoma (HCC), only selected patients can undergo resection because of the severity of the underlying cirrhosis or... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
-
Kim JY, Sinn DH, Gwak GY, Choi GS, Saleh AM, Joh JW, Cho SK, Shin SW, Carriere K, Ahn JH, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW
- KMID: 2373121
- Clin Mol Hepatol.
- 2016 Jun;22(2):250-258.
- doi: 10.3350/cmh.2016.0015
BACKGROUND/AIMS: Several studies have suggested that surgical resection (SR) can provide a survival benefit over transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) at the intermediate stage according to the Barcelona... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
-
Cho JY, Choi MS, Lee GS, Sohn W, Ahn J, Sinn DH, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW
- KMID: 2373152
- Clin Mol Hepatol.
- 2016 Dec;22(4):477-486.
- doi: 10.3350/cmh.2016.0048
BACKGROUND/AIMS: Radiofrequency ablation (RFA) is one of the most frequently applied curative treatments in patients with a single small hepatocellular carcinoma (HCC). However, the clinical significance of and risk factors... -
- CITED
-
- Close
- SHARE
-
- Close
